ICAZ LP 2.5 mg, extended-release capsule 90 tablets
Active ingredients: Isradipine
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release capsule90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ICAZ LP 2,5 mg, gélule à libération prolongée
- Pharmaceutical form
- gélule à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 90 comprimé(s)
- Marketing authorisation holder
- FARMACEUTICO SIT
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Mar 2007
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67966754CIP73739378CIP133400937393782Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ISRADIPINEgélule | 2,5 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.